Procter & Gamble's July 29 earnings call comes amid expectations for Q4 fiscal 2026 adjusted EPS of $1.42, down year-over-year, following Q3 results that showed 3% organic sales growth and a 3% rise in core EPS, with all ten categories and regions contributing. The company has maintained full-year guidance for organic sales in line to up 4% and core EPS in line to up 4%, though management flagged softer U.S. consumer demand, aggressive competition, and geopolitical pressures that could push results toward the lower end of ranges. Traders are focused on any commentary about consumer spending trends, innovation investments, and initial signals on fiscal 2027 outlook, which the firm has deferred until this report. Recent volume recovery in Q3 provides some momentum, but persistent margin and market headwinds create uncertainty around forward commentary.